• Difloxacin HCl: From Gyrase to Translation

  2026-09-22

  A translational framework for using Difloxacin HCl in antimicrobial susceptibility testing, multidrug resistance research, and hypothesis-driven assay design.

• IL-7, ER Proteostasis, and Translational Immunology

  2026-09-22

  A mechanistic analysis of how SARS-CoV-2 papain-like protease reshapes ER-associated degradation and how IL-7, human recombinant can help translational researchers separate viral proteostasis effects from immune-cell response biology.

• DIDS: From Chloride Transport to Cell-Fate Assays

  2026-09-21

  DIDS is more than a chloride channel blocker: it is a mechanistic probe whose interpretation depends on context, concentration, and orthogonal validation. This guide connects DIDS pharmacology with near-death tumor-cell reprogramming and provides an assay-design framework for separating transport effects from cell-fate biology.

• From Viral Immune Evasion to RNA Strategy

  2026-09-21

  A translational perspective on how the SARS-CoV-2 N protein–GADD34 mechanism informs controlled RNA design, assay validation, and strategic use of the HyperScribe™ SP6 High Yield RNA Synthesis Kit.

• TAK1–YAP Control of Gastric Cancer Stem Cells

  2026-09-20

  The reference study identifies TGFβ-activated kinase 1 (TAK1) as an upstream regulator of YAP stability and gastric cancer stem cell self-renewal. Its evidence links IL-6–responsive TAK1 to SOX2 and SOX9 transcription, tumorigenesis, and a mechanistic pathway that may help explain aggressive gastric cancer phenotypes.

• ECL Western Blotting Substrate: Workflow Guide

  2026-09-19

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection on immunoblots. It is intended for HRP chemiluminescent Western blot assays using X-ray film or CCD imaging, not for fluorescent, radioisotopic, or non-HRP detection workflows.

• GTP Solution for p21 mRNA-LNP Workflows

  2026-09-18

  A ready-to-use GTP Solution supports reproducible in vitro transcription, from p21 mRNA production to localized lipid nanoparticle studies. This practical guide connects nucleotide handling, RNA quality control, and the intravesical bladder cancer workflow reported in a 2026 FASEB Journal study.

• UV-Fenton Degradation of Sulfisomidine

  2026-09-18

  A 2020 Chemosphere study examined how UV-Fenton treatment degrades sulfisomidine and three other pharmaceuticals in ultrapure water and landfill-derived DTRO concentrate. Its main contribution was to connect degradation kinetics with transformation-product identification and HepG2 cytotoxicity evolution, showing that matrix effects and intermediate toxicity are essential when evaluating treatment performance.

• Verapamil HCl: Applied Calcium Signaling Workflows

  2026-09-17

  Use Verapamil HCl as a controlled L-type calcium channel blocker to connect calcium influx, intracellular drug exposure, apoptosis, and inflammatory signaling. This workflow-oriented guide shows how to design myeloma combination studies, arthritis inflammation model experiments, and troubleshooting controls without confusing channel blockade with transporter effects.

• SD 169: Reading p38 Signals in Dynamic Assays

  2026-09-17

  SD 169 (indole-5-carboxamide) is a selective ATP-competitive p38α/β inhibitor for dissecting inflammatory, metabolic, and neural signaling. This guide shows how to interpret inhibitor effects alongside p38 dephosphorylation, apoptosis, and functional readouts.

• Mouse Tissue Lysis Kit K1038: Direct PCR Guide

  2026-09-16

  The Mouse Tissue Lysis Kit K1038 provides a rapid tissue-digestion step for releasing genomic DNA from mouse tail, toe, or ear samples for direct PCR-based genotyping. It is intended for scientific molecular biology research and DNA analysis, not for diagnostic, clinical, or medical applications.

• DIDS: Workflow Guide for Chloride and Tumor Stress

  2026-09-16

  DIDS combines chloride-transport perturbation with a practical way to interrogate cell-death survival, vascular signaling, and tumor-stress phenotypes. This guide connects concentration-aware assay design with the prometastatic-state findings of the reference study while emphasizing solubility, selectivity, and interpretation controls.

• SU 5402: From RTK Biology to Translational Strategy

  2026-09-15

  SU 5402 is more than a receptor tyrosine kinase inhibitor: it is a mechanistic probe for testing how VEGFR2, FGFR, PDGFRβ, and downstream ERK1/2–STAT3 signaling shape tumor phenotypes. This thought-leadership perspective connects multiple myeloma research and cancer biology with carefully bounded opportunities in human iPSC-derived sensory neuron models of HSV-1 latency.

• SU 5402 for Reliable Cell Assays

  2026-09-15

  A scenario-driven guide to using SU 5402 (SKU A3843) in viability, proliferation, apoptosis, and receptor tyrosine kinase studies. It connects target-level potency, solvent handling, orthogonal readouts, and vendor-selection criteria to improve interpretation and reproducibility.

• DIDS: Practical Workflows for Chloride and Cancer Studies

  2026-09-14

  DIDS combines chloride-transport inhibition with context-dependent effects on TRPV1, vascular tone, mitochondrial membrane permeabilization, and tumor-cell stress. This guide translates those properties into assay-ready workflows, controls, troubleshooting decisions, and a cautious strategy for studying prometastatic states after near-death stress.

8554 records 1/571 page Next 12345 下5页 Last page